Recent Advances in Brain Tumor Therapy: Local Intracerebral Drug Delivery by Polymers
暂无分享,去创建一个
Henry Brem | Alessandro Olivi | A. Olivi | H. Brem | J. Weingart | Jon D. Weingart | C. Guerin | H. C. Lawson | Christopher Guerin | H. Christopher Lawson
[1] P. Burger,et al. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. , 1994, Cancer research.
[2] H Kalimo,et al. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. , 1997, Neurosurgery.
[3] Fred H. Hochberg,et al. Assumptions in the radiotherapy of glioblastoma , 1980, Neurology.
[4] D. Brat,et al. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models. , 1996, Cancer research.
[5] M. Tableman,et al. Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms. , 1995, Neurosurgery.
[6] A. Guarino,et al. Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880). , 1970, Cancer chemotherapy reports.
[7] R. Weichselbaum,et al. Combined effects of angiostatin and ionizing radiation in antitumour therapy , 1998, Nature.
[8] A. Olivi,et al. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas. , 1995, Journal of neurosurgery.
[9] William Arbuthnot Sir Lane,et al. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.
[10] H. Brem,et al. The role of minocycline in the treatment of intracranial 9L glioma. , 1995, Journal of neurosurgery.
[11] L. Liotta,et al. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.
[12] H. Brem,et al. The development of new brain tumor therapy utilizing the local and sustained delivery of chemotherapeutic agents from biodegradable polymers , 1999, Cancer.
[13] J. Folkman,et al. Angiogenesis and angiogenesis inhibition: an overview. , 1997, EXS.
[14] R J Reitemeier,et al. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer. , 1972, Cancer chemotherapy reports.
[15] Y. Kakeji,et al. Influence of an anti‐angiogenic treatment on 9L gliosarcoma: Oxygenation and response to cytotoxic therapy , 1995, International journal of cancer.
[16] D. Brat,et al. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors. , 1999, Cancer research.
[17] J. Chiras,et al. Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA) , 1991, Journal of Neuro-Oncology.
[18] D. Ettinger,et al. Phase I and pharmacodynamic study of taxol in refractory acute leukemias. , 1989, Cancer research.
[19] B. Teicher,et al. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. , 1992, Cancer research.
[20] L. Dillehay,et al. Effect of interstitial and/or systemic delivery of tirapazamine on the radiosensitivity of human glioblastoma multiforme in nude mice. , 1998, Radiation oncology investigations.
[21] R. Tamargo,et al. Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. , 1993, Cancer research.
[22] L. Dillehay,et al. Synthetic, implantable polymers for local delivery of IUdR to experimental human malignant glioma. , 1998, International journal of radiation oncology, biology, physics.
[23] D. Alberts,et al. Results of a Southwest Oncology Group phase III trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancer. , 1993, Oncology.
[24] R. Tamargo,et al. Angiogenesis inhibition by minocycline. , 1991, Cancer research.
[25] H. Hansen,et al. Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies. , 1972, Cancer chemotherapy reports.
[26] D. Ettinger. Evaluation of new drugs in untreated patients with small-cell lung cancer: its time has come. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] W. Saltzman,et al. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. , 1998, Cancer research.
[28] R. Tamargo,et al. The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. , 1992, Journal of neurosurgery.
[29] J. Laterra,et al. Selective endothelial growth inhibition by tetracyclines that inhibit collagenase. , 1992, Biochemical and biophysical research communications.
[30] T. Kinsella,et al. A phase I study of intravenous iododeoxyuridine as a clinical radiosensitizer. , 1985, International journal of radiation oncology, biology, physics.
[31] L. Helson,et al. High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. , 1981, Journal of neurosurgery.
[32] L. Dillehay,et al. Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma , 1997, Journal of Neuro-Oncology.
[33] S. Piantadosi,et al. The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: Phase I trial , 1995, Journal of Neuro-Oncology.
[34] J. Benoit,et al. Local and sustained delivery of 5‐fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma , 1999, Cancer.
[35] A. Olivi,et al. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. , 1994, Journal of neurosurgery.
[36] S. Piantadosi,et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas , 1995, The Lancet.
[37] M. Wiranowska,et al. Interferon-containing controlled-release polymers for localized cerebral immunotherapy. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[38] Manfred Westphal,et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. , 2003, Neuro-oncology.
[39] S. Piantadosi,et al. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors , 1997, Cancer Chemotherapy and Pharmacology.
[40] D. Brat,et al. Interstitial delivery of carboplatin via biodegradable Polymers is effective against experimental glioma in the rat , 1996, Cancer Chemotherapy and Pharmacology.
[41] K. Hess,et al. Surgical treatment of metastatic brain tumors , 1996, Journal of Neuro-Oncology.
[42] P M Black,et al. Brain tumors. Part 1. , 1991, The New England journal of medicine.
[43] J. Folkman,et al. The combination of antiagniogenic agents to inhibit primary tumor growth and metastasis , 1993 .
[44] H. Brem,et al. Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model , 1995, International journal of cancer.
[45] Y Maruyama,et al. A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.
[46] D. Long,et al. Interstitial delivery of dexamethasone in the brain for the reduction of peritumoral edema. , 1991, Journal of neurosurgery.
[47] R. Tamargo,et al. Brain biocompatibility of a biodegradable, controlled-release polymer in rats. , 1989, Journal of biomedical materials research.
[48] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[49] B. Teicher,et al. Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma. , 1995, Oncology research.
[50] R. Tamargo,et al. Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate , 1990, Journal of Neuro-Oncology.
[51] M. Ewend,et al. Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast carcinoma. , 1998, Neurosurgery.
[52] A. Friedman,et al. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. , 1991, Journal of neurosurgery.